US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biologics Market Research Reports & Industry Analysis

A biologic medical product or a biologic or biological, is a medicinal product such as a vaccine, blood or blood component, gene therapy, tissue, recombinant therapeutic protein, or living cells that are used as therapeutics to treat diseases. Biologics are created by biologic processes, rather than being chemically synthesized. Biologics can be composed of sugars, proteins, or nucleic acids or a complex combination of these substances.
They may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources that can be human, animal, or microorganism.
RSS Feeds

Biologics Industry Research & Market Reports

< prev 1    3  4  5  
Opportunity in the Indian Biopharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast
3/6/2015 | published by: Feedback Business Consulting Services Pvt. Ltd.
... Biopharmaceuticals current market scenario, structure and practices. In depth market scenario includes; Indian Biopharmaceuticals Market Size Market share of key players – Top companies Market size for Vaccines Market size for Diagnostics Market size for ...  |  read more...
USD 6,000
Biocatalysis & Biocatalysts Market By Type (Hydrolases, Oxidoreductases, Transferases, And Others), Application (Food & Beverages, Cleaning Agents, Agriculture & Feed, Biofuel Production, Biopharmaceuticals, And Others), And Geography - Forecast Till 2019
2/11/2015 | published by: MarketsandMarkets
... was estimated around 81 kilo tons in 2013, with the high share of around 70% held by North America and Europe together. The global biocatalysts market by volume is projected to grow at a CAGR ...  |  read more...
USD 4,650
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany
2/18/2015 | published by: GlobalData
... information on and analysis of the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare ...  |  read more...
USD 1,995
Cystic Fibrosis Market in Europe 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
... difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children. Rare diseases are those that affect ...  |  read more...
USD 3,000
Global Biologics and Biosimilars Industry - 2015
3/1/2015 | published by: QYResearch Group
... including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Biologics and Biosimilars markets in China and other countries or regions ...  |  read more...
USD 2,600
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019
2/18/2015 | published by: MarketsandMarkets
... is used to determine the presence of bacterial toxins in pharmaceutical, biotechnology, and medical device products, intended for medical or veterinary use. Spot checks of all batches of pharmaceutical, biotechnology, and medical device products are ...  |  read more...
USD 4,650
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan
2/18/2015 | published by: GlobalData
... of information on and analysis of the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and ...  |  read more...
USD 1,995
Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies
1/16/2015 | published by: Visiongain
... market and its submarkets to 2025, helping you stay ahead. The 222-page report provides 142 tables, charts, and graphs. Discover the growing trends of this industry. In particular, our new study lets you assess forecasted ...  |  read more...
USD 2,788
Active Pharmaceutical Ingredients (API) Market in India 2015-2019
1/14/2015 | published by: TechNavio - Infiniti Research Ltd.
... provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic ...  |  read more...
USD 3,000
Medical Technologies Market in the APAC Region 2015-2019
1/14/2015 | published by: TechNavio - Infiniti Research Ltd.
... the APAC region covers hospital hardware; technical aids for the disabled; reusable instruments; laboratory equipment; complementary therapy devices; healthcare facility products and adaptations; biologically derived devices; and technologies such as active implantable, anesthetic and respiratory, ...  |  read more...
USD 3,000
Subcutaneous Biologics: Products, Technologies and Delivery Systems
1/12/2015 | published by: Roots Analysis
... patient friendly format. Owing to its numerous compelling advantages, the concept has gained huge traction in recent years. The flexibility and convenience of subcutaneous administration over other routes of delivery, along with the increasing trend ...  |  read more...
USD 1,899
Biologicals in Oncology: Drug Pathway Analyzer 2015
1/12/2015 | published by: BioSeeker Group AB
... than 155 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 592 drug targets that are included in this drug-pathway analyzing tool. No less than ...  |  read more...
USD 11,025
Biologicals in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... in cancer. In addition, there are 26 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 1009 drugs. Biologicals In Oncology Drug Pipeline Update lists all drugs and ...  |  read more...
USD 11,246
Conference Documentation: Pharmaceutical Microbiology
1/21/2015 | published by: SMI Publishing, Ltd
... will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods and the latest technology Join us as we explore key issues ...  |  read more...
USD 788.78
Biological Therapies for Cancer: Technologies and Global Markets
1/1/2015 | published by: BCC Research
... compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. This report provides: An overview of the global markets and technologies for biological therapies for cancer Analyses of global market trends, with data from ...  |  read more...
USD 6,650
Biologic Therapeutic Drugs: Technologies and Global Markets
1/1/2015 | published by: BCC Research
... to $386.7 billion by the end of 2019 at compound annual growth rate (CAGR) of 10.6%. This report provides: An overview of the global market for biologic therapeutic drugs Analyses of global market trends, with ...  |  read more...
USD 6,650
Biopharmaceutical and Vaccine Production Markets (Mammalian Cell Production, Microbial Cell Production Market, Monoclonal Antibody Manufacturing, Other Recombinant Protein Manufacturing, Vaccine Manufacturing, Insulin Manufacturing Market)
8/29/2014 | published by: Kalorama Information
... stages of clinical drug testing for new biopharmaceuticals, as manufacturers decide when and how to risk production capital to upscale while anticipating FDA or EMA approval. During the past five years, estimates for biopharmaceuticals have ...  |  read more...
USD 3,995
Therapeutic Biological Drugs to 2020 Diseases, Devices, Dosing and Forecasts
10/1/2014 | published by: Greystone Research Associates
... sometimes limited by a lack of desirable attributes for adequate absorption or distribution. So it’s critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration ...  |  read more...
USD 3,850
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414
12/10/2014 | published by: Plunkett Research, Ltd.
... will save countless hours of research. Key Findings: Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $39.5 billion by 2021. Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry, including Average EBITDA, Operating ...  |  read more...
USD 1,995
Frontier Pharma: Parkinson’s Disease - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market relies on symptomatic treatments that target neuromodulatory receptors, the pipeline shows a diverse ...  |  read more...
USD 6,995
The Global Pre-Filled Syringe Market to 2024
10/27/2014 | published by: GMR Data Ltd.
... digit growth across the next decade. Buy this report today and acquire analysis of the state of the pre-filled syringes market in 2014 and a market forecastfor the period 2014-2024. Market forecasts are also provided ...  |  read more...
USD 2,500
Global Biologic Therapeutics Market 2014-2018
10/29/2014 | published by: TechNavio - Infiniti Research Ltd.
... arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, ...  |  read more...
USD 3,500
Frontier Pharma: Alzheimer’s Disease - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... GBI Research analysis revealed a high degree of innovation in this indication, with 46% of the pipeline being first-in-class products, acting on over 40 first-in-class molecular targets. In addition, the pipeline is characterized by the ...  |  read more...
USD 6,995
Novel Drug Reconstitution Systems Market, 2014-2024
12/2/2014 | published by: Roots Analysis
... by various processes such as lyophilisation or spray drying; these drugs are then reformulated into liquid form by mixing with a suitable diluent at the time of administration. The overall market of drug reconstitution systems ...  |  read more...
USD 1,899
The Russian Biopharmaceuticals and Biomedicine Market
12/16/2014 | published by: Frost & Sullivan
... and increasing disease burden are key long-term growth factors for the biotech industry. By 2025, almost a quarter of the Russian population will be aged 60 years or more. The most sizable segments of the ...  |  read more...
USD 1,500
< prev 1    3  4  5